Literature DB >> 9816317

Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.

B Seliger1, A Höhne, A Knuth, H Bernhard, B Ehring, R Tampé, C Huber.   

Abstract

Suppression of MHC class I expression is thought to allow tumor cells to escape immune surveillance mediated by CD8(+) CTLs. For stable MHC class I surface expression, multiple protein interactions are required for efficient assembly of MHC class I heavy chain and beta 2-microglobulin with endogenous peptides. Peptide processing and transport into the endoplasmic reticulum involves the genes of the transporters associated with antigen processing, TAP-1 and TAP-2, and the two components of the proteasome complex, the low molecular weight proteins LMP-2 and LMP-7. We selected human renal cell carcinoma (RCC) cells derived from a tumor that is thought to be controlled by host immunity to study the MHC class I antigen presentation machinery. Eleven RCC lines established from primary tumors were investigated for the mRNA and protein expression of MHC class I, TAP, and LMP genes. In addition, membrane stability of MHC class I was determined by incubation of the RCC cell lines at low temperature and in the presence of exogenous HLA-binding peptides. Our results revealed the existence of two different phenotypes of RCC cell lines. Group I displayed temperature-stable MHC class I surface expression associated with high, and in most cases coordinated, expression of MHC class I heavy and light chain, TAP and LMP transcripts, and proteins. Group II demonstrated a marked MHC class I instability at 37 degreesC associated with low but coordinated expression of the respective transcripts and proteins. MHC class I membrane expression of group II, but not of group I RCC cells, could be stabilized by incubation with specific MHC class I binding peptides. These results suggest an important role of the genes of the antigen presentation machinery in stable and efficient MHC class I surface expression of RCC cells. However, it has still to be defined whether deficient antigen processing is one of the mechanisms of RCC cells to escape the surveillance of the immune system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9816317

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

Review 1.  Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

Authors:  Annie A Wu; Virginia Drake; Huai-Shiuan Huang; ShihChi Chiu; Lei Zheng
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

2.  Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

Authors:  P Chames; S E Hufton; P G Coulie; B Uchanska-Ziegler; H R Hoogenboom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines.

Authors:  H Pandha; A Rigg; J John; N Lemoine
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

4.  Targeting the tumor microenvironment to improve natural killer cell-based immunotherapies: On being in the right place at the right time, with resilience.

Authors:  Shannon Murray; Andreas Lundqvist
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

5.  Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes.

Authors:  Christine G Stoehr; Maike Buettner-Herold; Esther Kamphausen; Simone Bertz; Arndt Hartmann; Barbara Seliger
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

Review 6.  Immune selection in neoplasia: towards a microevolutionary model of cancer development.

Authors:  S J Pettit; K Seymour; E O'Flaherty; J A Kirby
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

Review 7.  Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.

Authors:  Karthik Dhatchinamoorthy; Jeff D Colbert; Kenneth L Rock
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

8.  Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.

Authors:  Barbara Seliger; Diana Handke; Elisabeth Schabel; Juergen Bukur; Rudolf Lichtenfels; Reinhard Dammann
Journal:  J Transl Med       Date:  2009-10-26       Impact factor: 5.531

Review 9.  β2-Microglobulin-mediated signaling as a target for cancer therapy.

Authors:  Takeo Nomura; Wen-Chin Huang; Haiyen E Zhau; Sajni Josson; Hiromitsu Mimata; Leland W K Chung
Journal:  Anticancer Agents Med Chem       Date:  2014-03       Impact factor: 2.505

10.  Hippo signaling mediates proliferation, invasiveness, and metastatic potential of clear cell renal cell carcinoma.

Authors:  Ute Schütte; Savita Bisht; Lukas C Heukamp; Moritz Kebschull; Alexandra Florin; Jens Haarmann; Per Hoffmann; Gerd Bendas; Reinhard Buettner; Peter Brossart; Georg Feldmann
Journal:  Transl Oncol       Date:  2014-03-04       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.